Skip to main content
BAX logo

BAX

Baxter International Inc
$22.65 +0.96 (+4.43%) At close · Jul 2
Market Cap
$11.70B
Shares
516,469,008

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.65 Open$22.12 Day$22.02–22.76 52W$15.73–31.19 Avg vol 30d6.6M Short int41.7M · 8.1% float · 6.0d Short vol76% Last earningsApr 30, 2026 DataJan 2020–Jul 2026 Filing10-Q · Apr 30
Equibles Rating blended score · not investment advice
Overall
Buy
Technical · trend & momentum Buy
50 / 200-day cross no cross
+ Price vs 200-day avg +16% above
+ Price vs 50-day avg +19% above
RSI (14) 69 · neutral
+ MACD trend positive
52-week position 45% · mid-range
Sentiment · smart money Bullish
Trend (MA cross) 50d $19 › 200d $20 — 200d above 50d
+ Institutional flow 6 of 665 funds reported for Jun 30 · net +20.3K sh shares
Insider flow No net insider activity over 90 days
+ Short interest 8.07% of float · ▼ -1.8% MoM · 6.0 days cover
Volume signal Volume near normal
Institution breadth 665 holders — near 3-yr low, contrarian setup
Fundamentals Weak
Revenue growth +6% Y/Y
Gross margin 30%, contracting
EPS growth −47% Y/Y
+ Buyback $1.3B remaining
Balance sheet net debt $7.5B

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Jul 30, 2026 Est · unconfirmed · in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Apr 30, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Guidance & track record
      Latest guidance · from the 8-K filed Apr 30, 2026
      Reported sales growth from continuing operations · Full-Year 2026 Initiated 0% – 1%
      Adjusted earnings from continuing operations per diluted share · Full-Year 2026 Initiated $1.85 – $2.05

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      no cross Neutral
      Price vs 200-day avg
      +16% above Bullish
      Price vs 50-day avg
      +19% above Bullish
      RSI (14)
      69 · neutral Neutral
      MACD trend
      positive Bullish
      52-week position
      45% · mid-range Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $19 › 200d $20 — 200d above 50d
      Institutional flow Accumulating
      6 of 665 funds reported for Jun 30 · net +20.3K sh shares
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      8.07% of float · ▼ -1.8% MoM · 6.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      665 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $16 Now $23 · 45% 52-wk high $31
      vs 200-day avg +16% vs 50-day avg +19%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      BAX
      Baxter International Inc
      this stock
      $11.70B +18.6% +5.7% 8.1%
      ISRG
      Intuitive Surgical Inc
      $150.88B -24.8% +20.5% 51.8 2.2%
      MDLN
      Medline Inc.
      $119.55B +2.8% +11.5% 2.1%
      BDX
      Becton Dickinson & Co
      $43.56B +4.3% +8.2% 2.6%
      ALC
      Alcon Inc
      $33.97B -11.6% 1.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      665
      % held
      99.5%
      Reported
      6 of 665
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      478
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      41.7M
      Days to cover
      6.0d
      Change
      -747.6K sh
      View
      Short Volume
      Short vol %
      76%
      As of
      Jul 2, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      137
      Value
      $2.8K
      As of
      Jun 12, 2026
      View
      Off-Exchange
      Off-exchange %
      35.2%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Oct 31, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $11.2B
      Net income (FY)
      $-957.0M
      EPS diluted
      $-1.87
      View
      Buybacks
      Authorized
      $300.0M
      Remaining
      $1.3B
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Jun 30, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $645.2K
      Shares
      36.3K
      Filed
      May 18, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 9, 2026
      View
      Investor Relations
      Latest news
      Baxter Publishes 2025 Sustainabil…
      Published
      Jun 22, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      BAX +5.1% +22.2% +9.5% +6.2% +18.6%
      SPY +1.4% -1.3% +8.0% -0.3% +9.2%
      vs SPY +3.7% +23.4% +1.5% +6.5% +9.4%

      Capital returns

      Latest dividend
      $0.01 / share · ex May 29, 2026
      Cut 94.1%
      Paid (TTM)
      $0.20 / share · 4 payouts
      Dividend yield (TTM, derived)
      0.88%
      Buyback program · as of Mar 31, 2026
      Authorized
      $300.00M
      Spent (derived)
      Remaining
      $1.30B

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 10456 CUSIP 071813109 13F (30d) 30 filings 10 filers Visit website Investor relations